We recently celebrated the grand opening of our Quincy, MA pharmacy, located within the Department of Mental Health. We’re excited to celebrate this partnership and look forward to continuing to serve the Quincy community!
- Partner Highlights
- Pharmacy Openings
Grand Opening Event: Quincy, MA
Oct 9th, 2019
- Clinical Insights
- Treatment
Long-acting injectables in practice: What providers need to know
Genoa Healthcare recently hosted a webinar where Senior Product Manager Blake Shoemaker, PharmD, discussed long-acting injectables (LAIs) in practice. Watch the recording below for an overview on benefits, challenges and...
- Behavioral Health
- Clinical Insights
- Treatment
Why medication-assisted treatment is essential for improving patient outcomes
1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....
- 340B
Your questions, answered: 340B manufacturer pricing restrictions
Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...
- Behavioral Health
- Clinical Insights
- Treatment
Currently available and emerging therapy options for treatment-resistant depression
Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...